Psychiatric NP Scope of Practice for Depression in Pennsylvania

If you’re a psychiatrist or psychiatric nurse practitioner treating depression, you’ve probably fielded this question dozens of times: ‘Can I actually prescribe antidepressants—or other medications—through a telehealth visit?’

The short answer in 2026: Yes, absolutely. But like most things in healthcare, the devil’s in the details—especially when it comes to controlled substances, state licensing, and scope of practice rules that vary wildly depending on where your patient is sitting.

Let’s cut through the noise. This guide breaks down exactly what you need to know about prescribing depression medications via telehealth right now, including the federal DEA rules that just got extended through 2026, state-by-state variations that actually matter, and what the future holds for tele-prescribing in psychiatry.

The Current Reality: Federal Telehealth Rules Through 2026

Here’s the big picture: The DEA and HHS just extended COVID-era telehealth flexibilities through December 31, 2026. That means you can continue prescribing controlled substances—including Schedule II stimulants for ADHD or benzodiazepines for anxiety comorbid with depression—without ever seeing the patient in person first.

This is the fourth extension of rules that were supposed to sunset when the COVID Public Health Emergency ended. Without these extensions, we’d be back to the Ryan Haight Act’s strict requirement: no controlled substance prescriptions via telemedicine unless you’ve done at least one in-person exam.

What this means for your practice right now:

• You can initiate treatment for a new depression patient entirely via video visit
• If that patient needs adjunct therapy—say, a short-term benzodiazepine for severe anxiety or a stimulant for treatment-resistant depression—you can prescribe it via telehealth
• For pure depression medications (SSRIs, SNRIs, bupropion, mirtazapine, etc.), there was never a federal restriction—they’re not controlled substances, so telehealth prescribing has always been straightforward

The catch? These are temporary rules. The DEA is working on permanent regulations that will likely introduce a new ‘Special Registration for Telemedicine’ system. If you’re prescribing Schedule II medications via telehealth after 2026, you’ll probably need to obtain this registration.

What’s Coming: The DEA’s Proposed Permanent Rules

In January 2025, the DEA announced proposed rules that would formalize telehealth prescribing long-term:

For Schedule III–V medications (benzodiazepines, ketamine, some sleep aids): Any provider could apply for a telemedicine special registration to continue prescribing these without in-person visits.

For Schedule II medications (Adderall, Ritalin, Vyvanse): Only board-certified specialists—including psychiatrists—would qualify for ‘Advanced Telemedicine Prescribing’ registration. This is huge: it explicitly recognizes that psychiatric prescribers need to manage stimulants via telehealth for conditions like ADHD and treatment-resistant depression.

PMHNPs weren’t explicitly mentioned in the Schedule II category of the proposed rule, which could mean an extra hurdle down the road if you’re an NP who manages ADHD comorbid with depression. That’s still being debated in the comment period.

Bottom line: If you’re a psychiatrist treating depression via telehealth in 2026, federal law isn’t your barrier. You have clear authority to prescribe both controlled and non-controlled medications remotely. Just keep an eye on DEA announcements as we approach that December 2026 deadline.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs PMHNPs: Who Can Prescribe What?

Let’s talk scope of practice, because this is where things get messy—not at the federal level, but state by state.

Psychiatrists (MD/DO)

If you’re a board-certified psychiatrist, your scope of practice for treating depression is about as broad as it gets:

• Full diagnostic authority for all mental health conditions
• Unrestricted prescriptive authority for all medications, controlled or not
• No supervision requirements in any state
• Ability to prescribe off-label treatments (esketamine, certain anticonvulsants, atypical antipsychotics for augmentation)

The only limits are general medical regulations—you need to be licensed in the state where your patient is located, hold a DEA registration for controlled substances, and follow standard-of-care guidelines. That’s it.

Telehealth changes nothing about this. A video evaluation that meets the standard of care is legally equivalent to an in-person visit for prescribing purposes in all 50 states.

PMHNPs: It Depends Where You’re Practicing

Psychiatric Mental Health Nurse Practitioners are fully trained to diagnose and treat depression, but whether you can practice independently depends entirely on your state’s nurse practice act.

Full Practice Authority States (No Physician Supervision Required):

• California: As of January 2024, experienced PMHNPs (3+ years, nationally certified) can practice completely independently as ‘104 NPs’ under AB 890. This was a game-changer—California historically required physician oversight, but now you can manage a full depression caseload, prescribe all medications (including controlled substances), and even open your own telepsychiatry practice without a collaborating psychiatrist.

• New York: NPs with 3,600+ hours of practice can practice independently with no written collaborative agreement required (as of 2022). If you’re a PMHNP in New York who meets that threshold, you have essentially the same prescriptive authority as a psychiatrist—including controlled substances.

• Illinois: PMHNPs can obtain Full Practice Authority after completing 4,000 hours of clinical practice plus additional continuing education. With FPA, you can prescribe all schedules of controlled substances independently (with one caveat: if prescribing Schedule II opioids long-term, you must have a physician consultation process in place—but this rarely applies to depression treatment).

Restricted Practice States (Physician Collaboration Required):

• Texas: All APRNs must have a written Prescriptive Authority Agreement with a Texas physician. The physician doesn’t have to be on-site during telehealth visits, but they must meet with you regularly and be available for consultation. If you’re managing depression in Texas as a PMHNP, you’ll need a supervising psychiatrist or other physician on paper.

• Florida: This one’s tricky. Florida passed NP independence legislation in 2020, but it explicitly excluded psychiatric NPs. Only primary care NPs (family medicine, internal medicine, pediatrics) can practice autonomously in Florida. If you’re a PMHNP in Florida, you must practice under a protocol agreement with a supervising physician.

• Pennsylvania: No full practice authority yet, despite legislative efforts. PMHNPs need a collaborative agreement with a physician to prescribe. The good news? The physician doesn’t have to co-sign every prescription, just maintain an ongoing collaborative relationship.

What This Means for Prescribing via Telehealth:

Even in restricted states, you can absolutely provide telepsychiatry and prescribe depression medications—you just need the appropriate supervisory or collaborative structure in place. For platforms like Klarity Health, this is often built into the provider onboarding: in states requiring collaboration, you’re paired with a supervising psychiatrist who meets the legal requirements.

The medications themselves? In every state, PMHNPs with prescriptive authority (either independent or delegated) can prescribe:

• All non-controlled antidepressants (SSRIs, SNRIs, TCAs, MAOIs, etc.)
• Most Schedule III–V medications (benzodiazepines, low-dose stimulants in some states, sleep aids)
• Schedule II controlled substances in many states—though some (like Texas) have additional restrictions on where and when NPs can prescribe Schedule IIs

State-by-State Telehealth Prescribing Rules That Actually Matter

Federal rules set the floor, but states can—and do—add their own requirements. Here’s what you need to know in the states where most Klarity providers practice.

California: Wide Open for Telehealth

Key Rules:

• No state-level in-person exam requirement for prescribing via telehealth
• Telehealth visits must meet the same standard of care as in-person
• During COVID, California even allowed audio-only visits for mental health; video is preferred but not always mandatory
• Must check California’s prescription monitoring program (CURES) before prescribing controlled substances
• Must hold a California medical or nursing license—California is not part of the Interstate Medical Licensure Compact, so you need a full CA license even for telehealth-only practice

Practical Reality:California has a mature telehealth infrastructure and strong parity laws requiring insurers to cover tele-mental health equivalently to in-person care. The state actively encourages telepsychiatry to address provider shortages in rural areas (Inland Empire, Northern California).

If you’re a PMHNP with the new ‘104 NP’ designation, you’re effectively practicing at the top of your license—independently managing depression, prescribing controlled substances, and operating your own telehealth practice without physician involvement.

Texas: Flexible, With a Chronic Pain Carve-Out

Key Rules:

• Physician-patient relationship can be established via live audio-visual telemedicine (no in-person requirement)
• Chronic pain exception: Texas explicitly prohibits managing chronic pain with controlled substances via telemedicine unless you’ve seen the patient in person (or via video) within the last 90 days and meet other stringent conditions
• For mental health conditions—depression, anxiety, ADHD—there’s no state-level restriction on prescribing controlled substances via telehealth beyond federal DEA rules
• Must use video for initial evaluations; phone-only is generally insufficient for new patients
• NPs require a Prescriptive Authority Agreement with a Texas physician

Practical Reality:Texas had some of the country’s most restrictive telemedicine laws until 2017, when the legislature overhauled the rules. Now it’s quite workable for psychiatric practice. The chronic pain rule doesn’t typically impact depression treatment unless you’re co-managing a patient with significant somatic pain requiring long-term opioids (rare in primary depression care).

With 246 of 254 Texas counties designated as mental health shortage areas, there’s massive demand for telepsychiatry. Just make sure you’re using video—not phone—for new patient evaluations, and if you’re a PMHNP, have your collaborative agreement buttoned up with a Texas-licensed physician.

Florida: Friendly to Tele-Psychiatry (With a Twist)

Key Rules:

• Florida allows out-of-state providers to register for a Telehealth Registration without obtaining a full Florida license (unique among major states)
• Controlled substance exception for psychiatric care: Florida law prohibits prescribing Schedule II controlled substances via telehealth except for psychiatric disorders, inpatient/hospice care, or nursing home residents
• This means you can prescribe Adderall, Ritalin, or other Schedule IIs via telehealth for ADHD, treatment-resistant depression, or other psychiatric conditions—but you need to document that it’s part of a psychiatric treatment plan
• PMHNPs cannot practice independently in Florida; psychiatric NPs were excluded from the 2020 autonomy law and still require physician supervision

Practical Reality:Florida’s telehealth registration option is a huge draw for out-of-state psychiatrists. You can expand into one of the country’s largest patient markets without the cost and time of full licensure. The Schedule II exception for psychiatric disorders is explicit in statute—just make sure your documentation clearly ties any controlled substance prescription to a psychiatric diagnosis.

If you’re a PMHNP, you’ll need a Florida-based supervising psychiatrist with a signed protocol on file with the Board of Nursing. Not a dealbreaker, but something to arrange before you start seeing Florida patients.

New York: Progressive and Straightforward

Key Rules:

• No state-level in-person exam requirement for telehealth prescribing
• Strong telehealth parity laws; audio-only visits are still permitted for mental health in many cases (a COVID-era policy that’s been extended)
• Mandatory electronic prescribing for all medications, including controlled substances
• Experienced PMHNPs (3,600+ hours) can practice independently with no written collaborative agreement

Practical Reality:New York is one of the most provider-friendly states for telehealth mental health care. If you’re a PMHNP who meets the experience threshold, you have full prescriptive authority—including controlled substances—without physician oversight.

New York psychiatrists have been using telepsychiatry to serve upstate and rural areas for years, often linking NYC-based specialists with patients in underserved regions. The state’s regulations are clear and well-established, which means fewer compliance surprises.

Pennsylvania: Practice-Friendly, Regulation-Light

Key Rules:

• No comprehensive telehealth statute (several bills have failed), but the Department of State affirms that telehealth is legal if it meets standard of care
• No state-level ban on prescribing controlled substances via telehealth; defers to federal DEA rules
• Mandatory electronic prescribing for controlled substances
• NPs require a collaborative agreement with a physician; no full practice authority yet despite ongoing legislative efforts

Practical Reality:Pennsylvania’s lack of a formal telehealth law can feel uncertain, but in practice it’s quite workable. State boards have issued guidance confirming that providers can deliver care via telemedicine as long as they obtain patient consent, document appropriately, and maintain standard of care.

The state is desperate for psychiatric providers—particularly in rural ‘Pennsyltucky’—and actively reimburses telehealth equivalently under Medicaid. PMHNPs should have a collaborative agreement in place with a Pennsylvania physician, but the physician doesn’t need to attend telehealth sessions or co-sign prescriptions.

Illinois: Full Practice Authority and Strong Telehealth Laws

Key Rules:

• PMHNPs with Full Practice Authority (after 4,000 hours + continuing education) can prescribe all medications independently
• 2021 Telehealth Expansion Act mandates insurance parity and explicitly allows telehealth from any location
• No in-person exam requirement; telehealth is legally equivalent to in-person if standard of care is met
• Mandatory PDMP checks and electronic prescribing for controlled substances

Practical Reality:Illinois is a gold standard for PMHNP practice. If you have FPA designation, you can manage depression patients—including prescribing controlled substances—completely independently via telehealth. The 2021 law removed any ambiguity about telehealth legality and forbids insurers from requiring prior in-person visits.

Most psychiatric providers in Illinois are concentrated in Chicago and Springfield, leaving downstate regions severely underserved. Telepsychiatry fills that gap, and the state government actively funds initiatives to expand virtual mental health access.

The Economics of Building a Telehealth Depression Practice

Let’s talk money, because at the end of the day, you need to know if prescribing via telehealth is financially viable.

The DIY Marketing Trap

Many providers assume they can build a telehealth practice by investing in SEO, Google Ads, or directory listings. The math rarely works out the way you’d hope.

Realistic acquisition costs for a qualified psychiatric patient:

• SEO: Takes 6–12 months of consistent investment ($2,000–4,000/month for content, technical optimization, link building) before you see meaningful patient flow. Most solo providers don’t have the expertise or patience to see this through.
• Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked patients. Realistically, you’re looking at $200–400+ per booked patient when you factor in ad spend, testing, and lead qualification.
• Directory listings: Psychology Today charges a monthly fee and puts you on a page with hundreds of other providers. Zocdoc charges per booking ($35–100+) plus subscription fees. Total monthly cost adds up fast, and you’re competing for visibility.

When you add it all up—agency fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads—acquiring a psychiatric patient through DIY channels typically costs $200–500+ in real all-in costs. And that’s if you know what you’re doing.

The Platform Model: Pay Only for Results

This is where a platform like Klarity Health changes the equation.

Instead of gambling $3,000–5,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead—only when a qualified patient books with you.

Why this matters economically:

• No upfront marketing spend: You’re not burning cash on ads that may or may not work
• Pre-qualified patients: Leads are already matched to your specialty, availability, and the services you offer
• No wasted clicks: You’re not paying for leads that ghost or no-show; you pay when patients actually appear for appointments
• Built-in telehealth infrastructure: No separate platform costs for video, EMR, or billing systems
• Both insurance and cash-pay flow: Diversified revenue streams without building separate marketing funnels

Think of it this way: a solo psychiatrist spending $4,000/month on marketing might acquire 8–10 new patients if everything goes perfectly. On a pay-per-appointment platform, you’d pay roughly the same total amount—but only for patients who actually show up and get seen. That’s guaranteed ROI vs gambling on channels you may not understand.

What About Long-Term Revenue?

Here’s the reality: most depression patients stay in treatment for 6–18 months. If you acquire a patient for $200–300 (whether through DIY marketing or a platform fee), and they stay for an average of 12 visits at $150–250 per visit, your lifetime value is $1,800–3,000 per patient.

Even accounting for the acquisition cost, that’s strong economics—but only if you can actually fill your schedule. The advantage of a platform is speed and consistency: you can ramp up to a full caseload in weeks instead of months, without trial-and-error on marketing channels you’re not trained in.

Common Misconceptions About Telehealth Prescribing

Myth 1: ‘I can’t prescribe controlled substances via telehealth.’Reality: Thanks to the DEA extension through December 2026, you absolutely can. The Ryan Haight Act’s in-person requirement is currently suspended. Just follow standard prescribing practices—check the state PDMP, document your evaluation, and ensure the patient’s diagnosis justifies the medication.

Myth 2: ‘Telehealth prescribing is only legal in states with specific telehealth laws.’Reality: Nearly every state allows prescribing via telehealth as long as you meet the standard of care. Some states have detailed statutes (California, Illinois, Florida); others rely on guidance from medical or nursing boards (Pennsylvania). Either way, telehealth prescribing is legal in all 50 states—you just need to follow state-specific requirements around licensure, consent, and documentation.

Myth 3: ‘I need to see depression patients in person at least once.’Reality: Not under current federal or most state laws. A thorough telehealth evaluation—psychiatric history, mental status exam via video, assessment of safety—is sufficient to establish a valid patient relationship and prescribe medications. Some providers choose to do an initial in-person visit for complex cases or personal preference, but it’s not legally required.

Myth 4: ‘PMHNPs can’t prescribe the same medications as psychiatrists.’Reality: In full practice authority states, PMHNPs have essentially identical prescriptive authority. Even in restricted states, NPs with a collaborative agreement can prescribe the same range of antidepressants, anxiolytics, and (in most states) stimulants as psychiatrists. The difference is administrative (supervision requirements), not clinical scope.

Myth 5: ‘Telehealth patients are lower quality or less engaged.’Reality: Research consistently shows equivalent outcomes for telepsychiatry versus in-person care, with some studies showing better adherence because patients don’t have to take time off work or arrange transportation. The quality of the patient depends on how they’re sourced—cold leads from generic ads may be lower quality, but patients who specifically seek out mental health care via a vetted platform are often highly motivated.

What to Watch: Regulatory Changes on the Horizon

As we move through 2026, keep an eye on these developments:

1. DEA’s Final Telemedicine Rules (Expected Late 2026)The DEA is still collecting comments on its proposed special registration system. If finalized as written, psychiatrists would need to apply for ‘Advanced Telemedicine Prescribing’ registration to continue prescribing Schedule II medications via telehealth after December 31, 2026. The good news: psychiatry is explicitly recognized as a specialty that needs this authority. Just be prepared to complete whatever application process the DEA establishes.

2. State Scope of Practice ExpansionsSeveral states are considering bills to expand PMHNP independence (Pennsylvania, Texas, Ohio). If Texas or Florida pass full practice authority for psychiatric NPs, it would open up significant opportunities for independent telehealth practice in those massive markets.

3. Interstate Licensure CompactsThe APRN Compact (for nurse practitioners) is slowly gaining member states. Illinois adopted it in 2023, though it won’t be active until more states join. If this compact reaches critical mass, it could dramatically simplify multi-state telehealth practice for PMHNPs—similar to how the Interstate Medical Licensure Compact has helped psychiatrists.

4. Telehealth Payment ParitySeveral states are debating whether to make COVID-era telehealth payment parity permanent. This affects your reimbursement: if your state requires private insurers to pay the same rate for telehealth as in-person, it protects your revenue. If parity laws expire, insurers may try to reimburse telehealth visits at lower rates.

Practical Steps to Start Prescribing Depression Medications via Telehealth

If you’re ready to expand into telehealth (or shift more of your practice virtual), here’s your roadmap:

Step 1: Verify Your Licenses and Credentials

• Do you hold an active medical or nursing license in every state where you plan to see patients?
• Is your DEA registration current, and does it cover the states you’re practicing in?
• If you’re a PMHNP in a restricted state, do you have a collaborative agreement with a physician licensed in that state?

Step 2: Understand Your State’s Telehealth and Prescribing RulesUse the state-by-state breakdown above as a starting point, then verify current requirements with your state medical or nursing board. Key questions:

• Are there specific informed consent requirements for telehealth?
• Does your state mandate electronic prescribing?
• Are there any restrictions on prescribing controlled substances via telehealth (e.g., Florida’s psychiatric disorder exception)?

Step 3: Set Up Compliant Telehealth Infrastructure

• Video platform: Must be HIPAA-compliant (Zoom Healthcare, Doxy.me, or built into your EMR). Consumer Zoom doesn’t cut it.
• Electronic prescribing: If you’re prescribing controlled substances, you’ll need EPCS-certified software (most modern EMRs have this built in).
• PDMP access: Register for your state’s prescription monitoring program and build checking it into your workflow before prescribing any controlled medication.

Step 4: Master the Documentation EssentialsTelehealth visits require the same documentation as in-person, with a few additions:

• Informed consent for telehealth: Document that the patient understands the limitations and agrees to be treated via video
• Patient location: Always document where the patient is physically located during the visit (this determines which state’s laws apply)
• Emergency plan: Note how you’d handle a psychiatric emergency (suicidal ideation, acute psychosis) if it arose during a telehealth session
• Technology limitations: If video quality is poor or the visit is interrupted, document it and note whether the standard of care was still met

Step 5: Consider Patient Acquisition StrategyYou have two paths:

1. Build your own practice: Invest in SEO, Google Ads, directory listings, and wait 6–12 months to see meaningful patient flow. Budget $3,000–5,000/month and expect a learning curve.
2. Join a platform: Leverage existing patient flow, pay only for booked appointments, and ramp up quickly without marketing expertise or upfront spend.

For most providers—especially those starting out or scaling up—the platform model removes the risk entirely. You focus on clinical care; someone else handles patient acquisition, scheduling infrastructure, and billing support.

FAQ: Telehealth Prescribing for Depression Providers

Can I prescribe SSRIs and other antidepressants via telehealth without ever meeting a patient in person?Yes. Non-controlled antidepressants have never been subject to the Ryan Haight Act or federal telehealth restrictions. As long as you conduct a clinically appropriate evaluation via video (or audio in some states), document it, and meet your state’s standard of care, you can prescribe SSRIs, SNRIs, TCAs, MAOIs, or any other non-controlled medication.

What about benzodiazepines for anxiety comorbid with depression?Under current DEA rules (through December 2026), you can prescribe benzodiazepines (Schedule IV) via telehealth to a new patient without an in-person visit, as long as you conduct a proper psychiatric evaluation. After 2026, you may need to obtain a telemedicine special registration—but the DEA has proposed making this available to all prescribers for Schedule III–V medications.

Can I prescribe stimulants via telehealth for patients with depression and ADHD?Yes, through December 2026. Schedule II stimulants (Adderall, Ritalin, Vyvanse) are covered under the current DEA extension. After 2026, the DEA’s proposed rules would allow psychiatrists to obtain ‘Advanced Telemedicine Prescribing’ registration to continue this practice. PMHNPs may face additional restrictions under the proposed rules—stay tuned for final regulations.

Do I need malpractice insurance that covers telehealth?Most modern malpractice policies automatically cover telehealth as a routine mode of care delivery, but verify with your insurer. Some older policies may require a rider or updated language. If you’re practicing across state lines, make sure your coverage extends to every state where you’re licensed.

What happens if a patient is in crisis during a telehealth visit?Have a protocol in place before it happens. Best practices:

• Get the patient’s physical location and a callback number at the start of every visit
• Know how to contact local emergency services in the patient’s jurisdiction
• If a patient expresses imminent suicidal or homicidal intent, be prepared to initiate a welfare check or guide them to the nearest ER
• Document your crisis assessment and intervention in detail

Can I use audio-only (phone) visits to prescribe depression medications?It depends on the state and the situation. Many states allowed audio-only visits during COVID, and some (like New York and Illinois) have extended this for mental health care. However, most states prefer or require live video for establishing a new patient relationship and prescribing controlled substances. Check your state’s current guidance—video is always the safest bet legally.

If I’m a PMHNP in a restricted state, does my supervising physician need to be in the same state?Yes. If your state requires a collaborative agreement, the supervising physician must be licensed in that state. For example, a Texas PMHNP needs a Texas-licensed physician supervisor; a Pennsylvania PMHNP needs a Pennsylvania-licensed collaborating physician. The physician doesn’t need to be physically co-located or participate in telehealth sessions, but they must be licensed where the patient is located.

Can I prescribe controlled substances to patients in multiple states?Yes, but you need:

1. A medical or nursing license in each state where you’re treating patients
2. A DEA registration that covers each state (or a separate DEA registration for each state, depending on your practice setup)
3. Compliance with each state’s prescribing and telehealth rules

Multi-state practice is administratively complex, but platforms like Klarity can help streamline credentialing and compliance across states.

Why Join a Telehealth Platform Like Klarity Health?

If you’re a psychiatrist or PMHNP treating depression, joining a telehealth platform fundamentally changes your practice economics and workflow.

What Klarity Health Offers:

• Pre-qualified patient flow: No more waiting months for SEO to kick in or burning ad spend on unqualified leads
• Pay-per-appointment model: You only pay when patients actually book and show up—no monthly fees, no wasted marketing spend
• Built-in telehealth infrastructure: HIPAA-compliant video, integrated EMR, e-prescribing, and billing support all in one place
• Both insurance and cash-pay patients: Diversify your revenue without building separate workflows
• Credentialing support: We handle the state licensing and credentialing complexity so you can focus on patient care
• Flexible scheduling: Control your availability—work full-time, part-time, or as a side practice

The ROI is straightforward: Instead of gambling $3,000–5,000/month on marketing channels you’re not trained in, you pay a standard per-appointment fee only when you see patients. That’s predictable, scalable revenue without the risk.

For PMHNPs in restricted states: Klarity can connect you with supervising psychiatrists in states where collaboration is required, removing a major administrative barrier to multi-state practice.

For psychiatrists: Klarity gives you instant access to a national patient base without the overhead of building your own telehealth practice from scratch.

Ready to Start Prescribing Depression Medications Via Telehealth?

The regulatory landscape for telepsychiatry has never been more favorable. Federal rules explicitly support telehealth prescribing through at least 2026, and most states have embraced virtual mental health care as a permanent fixture of their healthcare systems.

Whether you’re a psychiatrist looking to expand into new markets or a PMHNP seeking flexibility and independence, telehealth offers a path to greater patient impact and stronger practice economics—if you can solve the patient acquisition challenge.

That’s where platforms like Klarity Health make the difference. We handle the patient flow, infrastructure, and compliance complexity so you can focus on what you do best: providing excellent psychiatric care to patients who desperately need it.

Explore joining Klarity Health’s provider network to start seeing depression patients via telehealth on your schedule, with guaranteed patient flow and none of the marketing headaches.

Citations

1. U.S. Department of Health & Human Services. (2026, January 2). HHS & DEA extend telemedicine flexibilities for prescribing controlled medications through 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. (2025, January 16). DEA announces three new telemedicine rules to continue open access to virtual prescribing. Retrieved from https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. California Board of Registered Nursing. (2023). Implementation of AB 890: Nurse Practitioner practice authority. Retrieved from https://www.rn.ca.gov/practice/ab890.shtml

4. Texas Administrative Code, Title 22, Part 9, §174.5. Telemedicine medical services and telemedicine medical service issuance of prescriptions (Updated January 15, 2025). Retrieved from https://txrules.elaws.us/rule/title22chapter174sec.174.5

5. Florida Statutes §456.47. Use of telehealth to provide services (2019, updated through 2025). Retrieved from https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service